A record number of procedures performed at HUS Neurosurgery in 2024 – waiting list is now under control
3.2.2025 12:39:53 EET | HUS | Press release
HUS Neurosurgery has been able to significantly shorten their surgery waiting list. In 2024, a record number of surgeries were performed, and more and more operations are ambulatory.

Access to neurosurgical care has significantly improved at HUS.
Currently, there are only 13 patients who have waited for their surgery longer than the guaranteed treatment time, which is six months, compared to more than 600 in fall 2023.
In total, 346 patients are on the neurosurgery waiting list within the care guarantee, whereas in August 2023 there were 1350 of them.
“The waiting list situation has greatly improved, and we estimate that by March nobody has to wait longer than the guaranteed maximum waiting time,” says Head Physician Mika Niemelä, head of neurosurgery from HUS Neurocenter.
The majority of the patients who have been on the waiting list for a long time need spinal fusion surgery.
The number of operations in neurosurgery hit a record high in 2024.
“Last year, we performed more surgeries than ever in our history; a total of 3850 procedures. The number includes neurosurgery for children and intravenous procedures,” Niemelä explains.
More ambulatory surgeries and improved efficiency
The number of ambulatory surgeries has increased by 70%.
“We now treat 50% of cervical spine patients and 60% of our non-urgent lumbar spine patients in ambulatory surgery. The most significant factors that enabled us to shorten the waiting list were increasing the number of ambulatory surgeries, improved efficiency at the ward, and shorter treatment times,” says Niemelä.
Access to neurosurgery declined during the COVID-19 pandemic and at the turn of the year 2022–2023. When the Bridge Hospital opened in early 2023, only three of the six operating rooms intended for neurosurgery were in use due to a nursing shortage.
Clearing the waiting list was the number one goal for 2024.
“We put significant effort in recruiting and training nursing professionals, and together with the Center for Perioperative and Intensive Care, we got more staff in the operating rooms and our ward. Together with the OR staff, our neurosurgeons were prepared to use all of the available operating room time as efficiently as possible, and we did everything we could to avoid cancelling surgeries. Our ward staff was also able to meet the increasing demand by developing their work,” explains Nina Forss, director of Neurocenter.
Now all the six operating rooms in the Bridge Hospital are in full use. Surgeries also continue in Hospital Orton until April. Children's surgeries are performed in New Children's Hospital.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Mika NiemeläHead of Neurosurgery, Head Physician, Neurocenter
mika.niemela@hus.fiImages

About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Mekanismerna bakom ruptur av hjärnaneurysm preciseras – HUS medverkar i en internationell studie6.7.2026 07:39:02 EEST | Pressmeddelande
HUS Helsingfors universitetssjukhus medverkar i en internationell studie som tillför ny information om varför en del hjärnaneurysm rupturerar. Resultaten kan i framtiden bidra till att bättre än i nuläget identifiera aneurysmen med störst rupturrisk och stödja utvecklingen av nya läkemedelsbehandlingar. Studien har publicerats i den ansedda tidskriften Nature Neuroscience.
Aivovaltimopullistuman puhkeamisen mekanismi tarkentuu – HUS mukana kansainvälisessä tutkimuksessa6.7.2026 07:39:02 EEST | Tiedote
HUS Helsingin yliopistollinen sairaala oli mukana kansainvälisessä tutkimuksessa, joka tuo uutta tietoa siihen, miksi osa aivovaltimopullistumista puhkeaa. Tulokset voivat tulevaisuudessa auttaa tunnistamaan nykyistä paremmin ne pullistumat, joiden puhkeamisriski on suurin ja tukemaan uusien lääkehoitojen kehittämistä. Tutkimus on julkaistu arvostetussa Nature Neuroscience -lehdessä.
Arbetet för babyvänlig verksamhet fortsätter – utvecklingsarbetet fortsätter med ny sammansättning2.7.2026 10:28:59 EEST | Pressmeddelande
Efter att Institutet för hälsa och välfärd THL:s nationella samordnande upphörde fortsätter arbetet för babyvänlig verksamhet i samarbete med alla välfärdsområden. Målet för den sakkunniggrupp som HUS har sammankallat är att trygga och utveckla babyvänlig vård i hela landet.
Vauvamyönteinen työ jatkuu – kehittämistyö jatkuu uudella kokoonpanolla2.7.2026 10:28:59 EEST | Tiedote
THL:n kansallisen koordinaation päätyttyä vauvamyönteisyystyö jatkuu yhteistyössä kaikkien hyvinvointialueiden kanssa. HUSin koollekutsuman asiantuntijaryhmän tavoitteena on turvata ja kehittää vauvamyönteistä hoitoa koko maassa.
Blodprov underlättar diagnostiken av lymfkörtelinflammationer i halsområdet hos barn1.7.2026 08:54:42 EEST | Pressmeddelande
En studie som genomförts vid HUS har bekräftat tillförlitligheten hos en blodprovsbaserad diagnostisk metod för lymfkörtelinflammationer i halsområdet hos barn som orsakas av miljömykobakterier. Ett blodprov är ett snabbare och för patienten mer skonsamt sätt att säkerställa diagnosen än invasiva metoder, såsom vävnadsprovtagning.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom